These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4133299)

  • 21. [Distribution of IgG subclasses in normal sera and in IgG myeloma proteins].
    Barandun S; Skvaril F; Morell A
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1174-6. PubMed ID: 5055037
    [No Abstract]   [Full Text] [Related]  

  • 22. Antigen-binding IgA myeloma proteins in mice: specificities to antigens containing -D 1 leads to 6 linked galactose side chains and a protein antigen in wheat.
    Potter M; Mushinski EB; Glaudemans CP
    J Immunol; 1972 Feb; 108(2):295-300. PubMed ID: 4114953
    [No Abstract]   [Full Text] [Related]  

  • 23. [Structure of defective G-1 JAM immunoglobulin called heavy chain disease].
    Snigurowicz JA; Terry WD
    Acta Haematol Pol; 1973; 4(2):97-101. PubMed ID: 4125360
    [No Abstract]   [Full Text] [Related]  

  • 24. Bence-Jones proteins and light chains of immunoglobulins (second of two parts).
    Solomon A
    N Engl J Med; 1976 Jan; 294(2):91-8. PubMed ID: 53788
    [No Abstract]   [Full Text] [Related]  

  • 25. Transplantable immunoglobulin-secreting tumors in rats. VI. N-terminal sequence variability in LOU/C/Wsl rat monoclonal heavy chains.
    Querinjean P; Bazin H; Kehoe JM; Capra JD
    J Immunol; 1975 Apr; 114(4):1375-8. PubMed ID: 804009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining sites of immunoglobulins that bind the 2,4-dinitrophenyl (DNP) group specifically.
    Haimovich J; Eisen HN; Givol D
    Ann N Y Acad Sci; 1971 Dec; 190():352-61. PubMed ID: 5290022
    [No Abstract]   [Full Text] [Related]  

  • 27. Neoplasms of immunoglobulin-producing cells in mice.
    Warner NL
    Recent Results Cancer Res; 1978; 64():316-24. PubMed ID: 310568
    [No Abstract]   [Full Text] [Related]  

  • 28. Preparation and characterization of anti-framework antibodies to the kappa-chain variable region (V kappa) of mouse immunoglobulins.
    Ben-Neriah Y; Lonai P; Givol D
    J Immunol; 1980 Feb; 124(2):691-5. PubMed ID: 6766163
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunoglobulin production in lymphoma cells: an immunoelectron microscopy study.
    Reyes F; Gourdin MF; Farcet JP; Breton-Gorius J; Dreyfus B
    Recent Results Cancer Res; 1978; 64():176-9. PubMed ID: 366695
    [No Abstract]   [Full Text] [Related]  

  • 30. Affinity labeling and topology of the antibody combining site.
    Givol D
    Essays Biochem; 1974; 10():73-103. PubMed ID: 4140089
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lipids of myeloma proteins. Lipids linked to normal and to myelomatous IgA].
    Goulley Y; Solera ML; Valdiguié P
    Pathol Biol (Paris); 1974 Sep; 22(7):567-74. PubMed ID: 4612460
    [No Abstract]   [Full Text] [Related]  

  • 32. Heavy chain diseases.
    Franklin EC; Frangione B; Cooper S
    Ann N Y Acad Sci; 1971 Dec; 190():457-66. PubMed ID: 5290025
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of haptens on the reaction of anti-idiotype antibody with a mouse anti-phosphorylcholine plasmacytoma protein.
    Sher A; Cohn M
    J Immunol; 1972 Jul; 109(1):176-8. PubMed ID: 5035242
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunoglobulins in lymphomas: quantitative determinations and detection of molecular dysmetabolic changes].
    Parmigiani G; Migliorini D; Bertazzoni A; Caprio G
    Ann Sclavo; 1972; 14(1):85-98. PubMed ID: 4592016
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunoglobulins and dysglobulinemias. Introduction and general data].
    Peltier AP
    Rev Rhum Mal Osteoartic; 1974 Oct; 41(10):557-71. PubMed ID: 4617916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of an antiserum specific for the Fabalpha fragment. Its use for detection of alpha-heavy chain disease protein by immunoselection.
    Doe WF; Spiegelberg HL
    J Immunol; 1979 Jan; 122(1):19-23. PubMed ID: 762416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-dimensional immunolectrophoresis as a diagnostic tool for heavy chain disease.
    Dammacco F; Antonaci S; Miglietta A
    Boll Ist Sieroter Milan; 1975; 54(6):460-5. PubMed ID: 56943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hypothetical space-filling model of the V-regions of the galactan-binding myeloma immunoglobulin J539.
    Feldmann RJ; Potter M; Glaudemans CP
    Mol Immunol; 1981 Aug; 18(8):683-98. PubMed ID: 6171725
    [No Abstract]   [Full Text] [Related]  

  • 39. The developmental history of the neoplastic plasma cell in mice: a brief review of recent developments.
    Potter M
    Semin Hematol; 1973 Jan; 10(1):19-32. PubMed ID: 4569738
    [No Abstract]   [Full Text] [Related]  

  • 40. Binding properties of a mouse immunoglobulin M myeloma protein with carbohydrate specificity.
    Young NM; Jocius IB; Leon MA
    Biochemistry; 1971 Aug; 10(18):3457-60. PubMed ID: 5118627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.